• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病中巨噬细胞移动抑制因子缺乏。

Macrophage migration inhibitory factor deficiency in chronic obstructive pulmonary disease.

机构信息

Section of Pulmonary, Critical Care, and Sleep Medicine, Yale Univ. School of Medicine, PO Box 208057, 300 Cedar St., New Haven, CT 06520-8057.

出版信息

Am J Physiol Lung Cell Mol Physiol. 2014 Mar 15;306(6):L487-96. doi: 10.1152/ajplung.00284.2013. Epub 2014 Jan 17.

DOI:10.1152/ajplung.00284.2013
PMID:24441872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3949087/
Abstract

The pathogenesis of chronic obstructive pulmonary disease (COPD) remains poorly understood. Cellular senescence and apoptosis contribute to the development of COPD; however, crucial regulators of these underlying mechanisms remain unknown. Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine that antagonizes both apoptosis and premature senescence and may be important in the pathogenesis of COPD. This study examines the role of MIF in the pathogenesis of COPD. Mice deficient in MIF (Mif(-/-)) or the MIF receptor CD74 (Cd74(-/-)) and wild-type (WT) controls were aged for 6 mo. Both Mif(-/-) and Cd74(-/-) mice developed spontaneous emphysema by 6 mo of age compared with WT mice as measured by lung volume and chord length. This was associated with activation of the senescent pathway markers p53/21 and p16. Following exposure to cigarette smoke, Mif(-/-) mice were more susceptible to the development of COPD and apoptosis compared with WT mice. MIF plasma concentrations were measured in a cohort of 224 human participants. Within a subgroup of older current and former smokers (n = 72), MIF concentrations were significantly lower in those with COPD [8.8, 95%CI (6.7-11.0)] compared with those who did not exhibit COPD [12.7 ng/ml, 95%CI (10.6-14.8)]. Our results suggest that both MIF and the MIF receptor CD74 are required for maintenance of normal alveolar structure in mice and that decreases in MIF are associated with COPD in human subjects.

摘要

慢性阻塞性肺疾病(COPD)的发病机制仍不清楚。细胞衰老和凋亡导致 COPD 的发生;然而,这些潜在机制的关键调节因子仍不清楚。巨噬细胞移动抑制因子(MIF)是一种多效细胞因子,拮抗细胞凋亡和过早衰老,可能在 COPD 的发病机制中起重要作用。本研究探讨了 MIF 在 COPD 发病机制中的作用。缺乏 MIF(Mif(-/-))或 MIF 受体 CD74(Cd74(-/-))的小鼠和野生型(WT)对照小鼠在 6 个月时衰老。与 WT 小鼠相比,Mif(-/-)和 Cd74(-/-)小鼠在 6 个月时通过肺容积和弦长测量自发发展为肺气肿。这与衰老途径标志物 p53/21 和 p16 的激活有关。在接触香烟烟雾后,与 WT 小鼠相比,Mif(-/-)小鼠更容易发生 COPD 和细胞凋亡。在 224 名人类参与者的队列中测量了 MIF 血浆浓度。在一组年龄较大的当前和以前的吸烟者(n = 72)中,与未患 COPD 的人相比,患有 COPD 的人的 MIF 浓度明显较低[8.8,95%CI(6.7-11.0)] [12.7ng/ml,95%CI(10.6-14.8)]。我们的结果表明,MIF 和 MIF 受体 CD74 都需要维持小鼠正常的肺泡结构,并且 MIF 的减少与人类 COPD 有关。

相似文献

1
Macrophage migration inhibitory factor deficiency in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中巨噬细胞移动抑制因子缺乏。
Am J Physiol Lung Cell Mol Physiol. 2014 Mar 15;306(6):L487-96. doi: 10.1152/ajplung.00284.2013. Epub 2014 Jan 17.
2
A functional macrophage migration inhibitory factor promoter polymorphism is associated with reduced diffusing capacity.功能性巨噬细胞移动抑制因子启动子多态性与弥散能力降低有关。
Am J Physiol Lung Cell Mol Physiol. 2019 Feb 1;316(2):L400-L405. doi: 10.1152/ajplung.00439.2018. Epub 2018 Dec 6.
3
Brief report: Enhanced DRα1-mMOG-35-55 treatment of severe EAE in MIF-1-deficient male mice.简要报告:增强型 DRα1-mMOG-35-55 治疗 MIF-1 缺陷型雄性小鼠的严重 EAE。
Cell Immunol. 2021 Dec;370:104439. doi: 10.1016/j.cellimm.2021.104439. Epub 2021 Sep 11.
4
"Near Cure" treatment of severe acute EAE in MIF-1-deficient female and male mice with a bifunctional MHCII-derived molecular construct.用一种双功能 MHCII 衍生分子构建物对 MIF-1 缺陷雌性和雄性小鼠的严重急性 EAE 进行“近治愈”治疗。
Cell Immunol. 2022 Aug;378:104561. doi: 10.1016/j.cellimm.2022.104561. Epub 2022 Jun 11.
5
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病自我管理的计算机和移动技术干预措施。
Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2.
6
Sirtuin 3 deficiency exacerbates emphysema and lung inflammation in a murine model of chronic obstructive pulmonary disease.沉默调节蛋白3缺乏会加重慢性阻塞性肺疾病小鼠模型中的肺气肿和肺部炎症。
Am J Physiol Lung Cell Mol Physiol. 2025 Aug 1;329(2):L200-L213. doi: 10.1152/ajplung.00212.2024. Epub 2025 Jun 25.
7
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.免疫刺激剂与安慰剂在预防慢性支气管炎或慢性阻塞性肺疾病成人恶化中的比较。
Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013343. doi: 10.1002/14651858.CD013343.pub2.
8
Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease.吸入性皮质类固醇联合吸入长效β2-激动剂和长效抗胆碱能药物治疗慢性阻塞性肺疾病。
Cochrane Database Syst Rev. 2023 Dec 6;12(12):CD011600. doi: 10.1002/14651858.CD011600.pub3.
9
Pulmonary rehabilitation for chronic obstructive pulmonary disease.慢性阻塞性肺疾病的肺康复治疗
Cochrane Database Syst Rev. 2015 Feb 23;2015(2):CD003793. doi: 10.1002/14651858.CD003793.pub3.
10
HMGB1-mediated pyroptosis promotes inflammation and contributes to skeletal muscle atrophy induced by cigarette smoke.高迁移率族蛋白B1介导的细胞焦亡促进炎症反应,并导致香烟烟雾诱导的骨骼肌萎缩。
Am J Physiol Cell Physiol. 2025 Jul 1;329(1):C325-C340. doi: 10.1152/ajpcell.01014.2024. Epub 2025 May 30.

引用本文的文献

1
Protocol for differentiating primary human small airway epithelial cells at the air-liquid interface.在气液界面分化原代人小气道上皮细胞的方案。
Am J Physiol Lung Cell Mol Physiol. 2025 Jun 1;328(6):L757-L771. doi: 10.1152/ajplung.00380.2024. Epub 2025 Apr 17.
2
Risk and Protective Factors of COPD Among Smokers: A Cross-Sectional Study Using NHANES Database.吸烟者中慢性阻塞性肺疾病的风险和保护因素:一项使用美国国家健康与营养检查调查(NHANES)数据库的横断面研究。
Int J Chron Obstruct Pulmon Dis. 2025 Apr 11;20:1027-1038. doi: 10.2147/COPD.S489581. eCollection 2025.
3
WISP1 and Macrophage Migration Inhibitory Factor in Respiratory Inflammation: Novel Insights and Therapeutic Potentials for Asthma and COPD.WISP1 和巨噬细胞移动抑制因子在呼吸道炎症中的作用:哮喘和 COPD 的新见解和治疗潜力。
Int J Mol Sci. 2024 Sep 18;25(18):10049. doi: 10.3390/ijms251810049.
4
Single-cell transcriptome analysis deciphers the CD74-mediated immune evasion and tumour growth in lung squamous cell carcinoma with chronic obstructive pulmonary disease.单细胞转录组分析揭示了慢性阻塞性肺疾病伴发肺鳞状细胞癌中CD74介导的免疫逃逸和肿瘤生长。
Clin Transl Med. 2024 Aug;14(8):e1786. doi: 10.1002/ctm2.1786.
5
Macrophage migration inhibitory factor reversed senescent phenotype in human chondrocytes in vitro.巨噬细胞移动抑制因子在体外逆转人软骨细胞的衰老表型。
Mol Biol Rep. 2024 Jan 21;51(1):154. doi: 10.1007/s11033-023-09101-0.
6
Macrophage migration inhibitory factor family proteins are multitasking cytokines in tissue injury.巨噬细胞移动抑制因子家族蛋白是组织损伤中的多功能细胞因子。
Cell Mol Life Sci. 2022 Jan 29;79(2):105. doi: 10.1007/s00018-021-04038-8.
7
Characterization of the COPD alveolar niche using single-cell RNA sequencing.使用单细胞 RNA 测序技术对 COPD 肺泡龛进行特征分析。
Nat Commun. 2022 Jan 25;13(1):494. doi: 10.1038/s41467-022-28062-9.
8
A new cytokine target for chronic obstructive pulmonary disease?慢性阻塞性肺疾病的一个新的细胞因子靶点?
EBioMedicine. 2021 Jul;69:103479. doi: 10.1016/j.ebiom.2021.103479. Epub 2021 Jul 10.
9
A high docosahexaenoic acid diet alters lung inflammation and recovery following repetitive exposure to aqueous organic dust extracts.高二十二碳六烯酸饮食改变重复暴露于水相有机粉尘提取物后肺炎症和恢复。
J Nutr Biochem. 2021 Nov;97:108797. doi: 10.1016/j.jnutbio.2021.108797. Epub 2021 Jun 12.
10
A Preview of Selected Articles.部分文章预览。
Stem Cells Transl Med. 2020 Nov;9(11):1273-1276. doi: 10.1002/sctm.20-0437.

本文引用的文献

1
Peripheral blood mononuclear cell gene expression in chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者外周血单个核细胞基因表达。
Am J Respir Cell Mol Biol. 2013 Aug;49(2):316-23. doi: 10.1165/rcmb.2012-0230OC.
2
Role of migratory inhibition factor in age-related susceptibility to radiation lung injury via NF-E2-related factor-2 and antioxidant regulation.迁移抑制因子通过 NF-E2 相关因子-2 和抗氧化调节在与年龄相关的放射性肺损伤易感性中的作用。
Am J Respir Cell Mol Biol. 2013 Aug;49(2):269-78. doi: 10.1165/rcmb.2012-0291OC.
3
Aging, cellular senescence, and cancer.衰老、细胞衰老和癌症。
Annu Rev Physiol. 2013;75:685-705. doi: 10.1146/annurev-physiol-030212-183653. Epub 2012 Nov 8.
4
TLR4 deficiency promotes autophagy during cigarette smoke-induced pulmonary emphysema.TLR4 缺陷促进香烟烟雾诱导的肺气肿中的自噬。
Am J Physiol Lung Cell Mol Physiol. 2012 Nov 1;303(9):L748-57. doi: 10.1152/ajplung.00102.2012. Epub 2012 Sep 14.
5
Toll-like receptor (TLR2 and TLR4) polymorphisms and chronic obstructive pulmonary disease.Toll 样受体(TLR2 和 TLR4)多态性与慢性阻塞性肺疾病。
PLoS One. 2012;7(8):e43124. doi: 10.1371/journal.pone.0043124. Epub 2012 Aug 28.
6
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.全球慢性阻塞性肺疾病诊断、管理和预防策略:GOLD 执行摘要。
Am J Respir Crit Care Med. 2013 Feb 15;187(4):347-65. doi: 10.1164/rccm.201204-0596PP. Epub 2012 Aug 9.
7
Chronic obstructive pulmonary disease.慢性阻塞性肺疾病。
Lancet. 2012 Apr 7;379(9823):1341-51. doi: 10.1016/S0140-6736(11)60968-9. Epub 2012 Feb 6.
8
The association of Toll-like receptor 4 gene polymorphisms with the development of emphysema in Japanese subjects: a case control study.日本人群中Toll样受体4基因多态性与肺气肿发生的关联:一项病例对照研究。
BMC Res Notes. 2012 Jan 18;5:36. doi: 10.1186/1756-0500-5-36.
9
Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus.巨噬细胞移动抑制因子基因对人类系统性红斑狼疮发展及严重程度的双重作用。
Arthritis Rheum. 2011 Dec;63(12):3942-51. doi: 10.1002/art.30624.
10
Geographic variations in heart failure hospitalizations among medicare beneficiaries in the Tennessee catchment area.田纳西流域医保受益人心力衰竭住院的地理差异。
Am J Med Sci. 2012 Jan;343(1):71-7. doi: 10.1097/MAJ.0b013e318223bbd4.